Liu et al found that TLR4 was abnormal expression in ITP patients and demonstrated that TLR4 in combination with FcγRII could cause DCs to express cytokines IL-23 then promote effector Th17 cell responses [25]. This evidence concerns the gene TLR4 and autoimmune thrombocytopenic purpura.